Healthcare
Monday, April 4, 2016
BRIEF-Xbrane Biopharma: second milestone in commercializing Ranibizumab biosimilar Xlucane in Iran
* Said on Monday had reached second milestone in commercializing Ranibizumab biosimilar Xlucane together with its partner Helvetic Biopharma in Iran
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment